Clinical trials
Phase 2/3 Carcinoma, Squamous Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Completed | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire Dijon | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Dana-Farber Cancer Institute | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Henry Ford Health System | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Sesen Bio, Inc. | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 9 |
| Head and Neck Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Mouth Neoplasms | 1 |
| Neoplasms, Squamous Cell | 1 |
| Oropharyngeal Neoplasms | 1 |
| Recurrence | 1 |
| Skin Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.